Osteopenia News and Research

RSS
Osteopenia is a condition where bone mineral density is lower than normal. It is considered by many doctors to be a precursor to osteoporosis. However, not every person diagnosed with osteopenia will develop osteoporosis. More specifically, osteopenia is defined as a bone mineral density T-score between -1.0 and -2.5.
NPS submits NDA CMC section to FDA for GATTEX

NPS submits NDA CMC section to FDA for GATTEX

FDA approves Gilead's Complera for treatment of HIV-1 infection

FDA approves Gilead's Complera for treatment of HIV-1 infection

Unigene second quarter revenue decreases to $2.5 million

Unigene second quarter revenue decreases to $2.5 million

Osteoporosis, low bone density common in people with early-stage MS

Osteoporosis, low bone density common in people with early-stage MS

Varicocele surgery may increase testosterone production

Varicocele surgery may increase testosterone production

Low testosterone linked to varicoceles

Low testosterone linked to varicoceles

Zoledronate at lower dose effective in reducing risk of osteoporotic fractures

Zoledronate at lower dose effective in reducing risk of osteoporotic fractures

The Endocrine Society releases clinical practice guideline on Vitamin D deficiency

The Endocrine Society releases clinical practice guideline on Vitamin D deficiency

Patients with celiac disease 4.5 times more likely to develop osteoporosis

Patients with celiac disease 4.5 times more likely to develop osteoporosis

GATTEX Phase 3 study results in adult short bowel syndrome presented at DDW 2011

GATTEX Phase 3 study results in adult short bowel syndrome presented at DDW 2011

Unigene first quarter net loss decreases 58% to $6.6 million

Unigene first quarter net loss decreases 58% to $6.6 million

Abbott submits ARCHITECT 25-OH Vitamin D assay application to FDA for clearance

Abbott submits ARCHITECT 25-OH Vitamin D assay application to FDA for clearance

Positive results from Tarsa's oral calcitonin Phase III trial against postmenopausal osteoporosis

Positive results from Tarsa's oral calcitonin Phase III trial against postmenopausal osteoporosis

Commentary examines current guidelines for cancer survivors, suggests future nutrition research

Commentary examines current guidelines for cancer survivors, suggests future nutrition research

Researchers find breast cancer therapy contributes to early-in-life hip fractures in women

Researchers find breast cancer therapy contributes to early-in-life hip fractures in women

GATTEX Phase 3 pivotal study reaches primary efficacy endpoint of reducing PN in patients with SBS

GATTEX Phase 3 pivotal study reaches primary efficacy endpoint of reducing PN in patients with SBS

Unintended direct conflict between pharmaceutical marketing and public health

Unintended direct conflict between pharmaceutical marketing and public health

NPS completes treatment phase in GATTEX Phase 3 registration study in short bowel syndrome

NPS completes treatment phase in GATTEX Phase 3 registration study in short bowel syndrome

Tel Aviv University uncovers muscle-stem cell mechanism in aging

Tel Aviv University uncovers muscle-stem cell mechanism in aging

Gilead submits Truvada/TMC278 single-tablet regimen NDA to FDA

Gilead submits Truvada/TMC278 single-tablet regimen NDA to FDA

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.